Department of Radiology
Found 22 results
Filters: Keyword is Glioblastoma  [Clear All Filters]
2024
Krugman J, Patel K, Cantor A, Snuderl M, Cooper B, Zan E, Radmanesh A, E Hidalgo T, Nicolaides T.  2024.  Pediatric glioblastoma in the setting of constitutional mismatch-repair deficiency treated with upfront lomustine and nivolumab.. Pediatr Blood Cancer. 71(1):e30757.
2023
De Martino M, Daviaud C, Minns HE, Lazarian A, Wacker A, Costa APaula, Attarwala N, Chen Q, Choi S-W, Rabadàn R et al..  2023.  Radiation therapy promotes unsaturated fatty acids to maintain survival of glioblastoma.. Cancer Lett. 570:216329.
2019
Ivanidze J, Lum M, Pisapia D, Magge R, Ramakrishna R, Kovanlikaya I, Fine HA, Chiang GC.  2019.  MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma.. J Neuroimaging. 29(3):357-363.
2018
Bae J, Zhang J, Wadghiri YZaim, Minhas ASingh, Poptani H, Ge Y, Kim SGene.  2018.  Measurement of blood-brain barrier permeability using dynamic contrast-enhanced magnetic resonance imaging with reduced scan time.. Magn Reson Med. 80(4):1686-1696.
2017
Chiang GC, Galla N, Ferraro R, Kovanlikaya I.  2017.  The Added Prognostic Value of Metabolic Tumor Size on FDG-PET at First Suspected Recurrence of Glioblastoma Multiforme.. J Neuroimaging. 27(2):243-247.
Galla N, Chiang G, Chakraborty S, Singh R, A Tsiouris J, Boockvar J, Kovanlikaya I.  2017.  Apparent diffusion coefficient changes predict survival after intra-arterial bevacizumab treatment in recurrent glioblastoma.. Neuroradiology. 59(5):499-505.
2016
Hicks MJ, Chiuchiolo MJ, Ballon D, Dyke JP, Aronowitz E, Funato K, Tabar V, Havlicek D, Fan F, Sondhi D et al..  2016.  Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma.. PLoS One. 11(10):e0162978.
Munjal S, Pahlajani S, Baxi A, Ferrando S.  2016.  Delayed Diagnosis of Glioblastoma Multiforme Presenting With Atypical Psychiatric Symptoms.. Prim Care Companion CNS Disord. 18(6)
Wang S, Martinez-Lage M, Sakai Y, Chawla S, Kim SG, Alonso-Basanta M, Lustig RA, Brem S, Mohan S, Wolf RL et al..  2016.  Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.. AJNR Am J Neuroradiol. 37(1):28-36.
Bander ED, Jones SH, Kovanlikaya I, Schwartz TH.  2016.  Utility of tubular retractors to minimize surgical brain injury in the removal of deep intraparenchymal lesions: a quantitative analysis of FLAIR hyperintensity and apparent diffusion coefficient maps.. J Neurosurg. 124(4):1053-60.
2015
Hicks MJ, Funato K, Wang L, Aronowitz E, Dyke JP, Ballon DJ, Havlicek DF, Frenk EZ, De BP, Chiuchiolo MJ et al..  2015.  Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma.. Cancer Gene Ther. 22(1):1-8.
2014
Wang S, Kim SJ, Poptani H, Woo JH, Mohan S, Jin R, Voluck MR, O'Rourke DM, Wolf RL, Melhem ER et al..  2014.  Diagnostic utility of diffusion tensor imaging in differentiating glioblastomas from brain metastases.. AJNR Am J Neuroradiol. 35(5):928-34.
2013
Evans MJ, Holland JP, Rice SL, Doran MG, Cheal SM, Campos C, Carlin SD, Mellinghoff IK, Sawyers CL, Lewis JS.  2013.  Imaging tumor burden in the brain with 89Zr-transferrin.. J Nucl Med. 54(1):90-5.
2012
Burkhardt J-K, Santillan A, Hofstetter CP, Christos P, Berry N, Shin BJ, Foley CP, Gürsel DB, Ballon DJ, Y Gobin P et al..  2012.  Intra-arterial bevacizumab with blood brain barrier disruption in a glioblastoma xenograft model.. J Exp Ther Oncol. 10(1):31-7.
Jeon JY, Kovanlikaya I, Boockvar JA, Mao X, Shin B, Burkhardt JK, Kesavabhotla K, Christos P, Riina H, Shungu DC et al..  2012.  Metabolic response of glioblastoma to superselective intra-arterial cerebral infusion of bevacizumab: a proton MR spectroscopic imaging study.. AJNR Am J Neuroradiol. 33(11):2095-102.
Burkhardt J-K, Hofstetter CP, Santillan A, Shin BJ, Foley CP, Ballon DJ, Y Gobin P, Boockvar JA.  2012.  Orthotopic glioblastoma stem-like cell xenograft model in mice to evaluate intra-arterial delivery of bevacizumab: from bedside to bench.. J Clin Neurosci. 19(11):1568-72.
2009
Wang S, Kim S, Chawla S, Wolf RL, Zhang W-G, O'Rourke DM, Judy KD, Melhem ER, Poptani H.  2009.  Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.. Neuroimage. 44(3):653-60.
2007
Dyke JP, Sanelli PC, Voss HU, Serventi JV, Stieg PE, Schwartz TH, Ballon D, Shungu DC, Pannullo SC.  2007.  Monitoring the effects of BCNU chemotherapy Wafers (Gliadel) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla.. J Neurooncol. 82(1):103-10.
2004
Gondi CS, Lakka SS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Tung CH, Weissleder R, Rao JS.  2004.  Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.. Cancer Res. 64(12):4069-77.
Shah K, Tung C-H, Chang C-H, Slootweg E, O'Loughlin T, Breakefield XO, Weissleder R.  2004.  In vivo imaging of HIV protease activity in amplicon vector-transduced gliomas.. Cancer Res. 64(1):273-8.
1997
Kabalka GW, Smith GT, Dyke JP, Reid WS, Longford CP, Roberts TG, Reddy NK, Buonocore E, Hübner KF.  1997.  Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.. J Nucl Med. 38(11):1762-7.
1983
Andreou J, George AE, Wise A, de Leon M, Kricheff II, Ransohoff J, Foo SH.  1983.  CT prognostic criteria of survival after malignant glioma surgery.. AJNR Am J Neuroradiol. 4(3):488-90.